Surgical Management of Breast Cancer

Seminars in Oncology

Volumn 34, Issue 3, 2007, Pages 234-240

  Vazquez, Bianca ^a   Rousseau, Dennis ^a   Hurd, Thelma C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST RECONSTRUCTION; CARCINOMA IN SITU; CLINICAL FEATURE; HUMAN; INTRADUCTAL CARCINOMA; MALE BREAST; MASTECTOMY; PREGNANCY; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; MALE; MASTECTOMY; MASTECTOMY, SEGMENTAL; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SENTINEL LYMPH NODE BIOPSY;

EID: 34249893891     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.03.013     Document Type: Article

References (65)

1. Poggi M.M., Danforth D.N., Sciuto L.C., et al. Eighteen-years results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer 98 (2003) 697-702
2. Hurd T.C., Proulx G.M., Edge S.B., et al. Current problems in treatment of early-stage breast cancer. Curr Problems Cancer 23 (1999) 144-228
3. Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30 (2001) 96-102
4. Bleicher R.J., Hansen N.M., and Giuliano A.E. Skin-sparing mastectomy specialty bias and worldwide lack of consensus. Cancer 98 (2003) 2316-2321
5. Anderson B.O., Calhoun K.E., and Rosen E.L. Evolving concepts in the management of lobular neoplasia. J Natl Compr Cancer Netw 4 (2006) 511-522
6. Adepoju L.J., Symmans W.F., and Babiera G.V. Impact of concurrent proliferative high risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast conserving surgery. Cancer 106 (2006) 42-50
7. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97 (2005) 1652-1662
8. Walt A.J., Simon M., and Swanson G.M. The continuing dilemma of lobular carcinoma in situ. Arch Surg 127 (1992) 904-907
9. Trentham-Dietz A., Newcomb P.A., Storer B.E., et al. Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9 (2000) 697-703
10. Frykberg E.R. Lobular carcinoma in situ of the breast. Breast J 5 (1999) 296-303
11. Sasson A.R., Fowble B., Hanlon A., et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91 (2001) 1862-1869
12. Rosen P.P., Kosloff C., Lieberman P.H., et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2 (1978) 225-251
13. Swain S.M. Overview and treatment of lobular carcinoma in situ. In: Silverstein M.J. (Ed). Ductal Carcinoma In Situ of the Breast (1995), Williams & Wilkins, Baltimore, MD 595-609
14. Schnitt S., and Morrow M. Lobular carcinoma in situ: Current concepts controversies. Semin Diagn Pathol 16 (1999) 209-223
15. Eusebi V., Magalhaes F., and Azzopardi J.G. Pleomorphic lobular carcinoma of the breast: An aggressive tumor showing apocrine differentiation. Hum Pathol 23 (1992) 655-662
16. Stolier A.J., Barre G., Bolton J.S., et al. Breast conservation therapy of invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status. Am Surg 70 (2004) 818-821
17. Lakhani S.R., Audretsch W., Cleton-Jensen A.M., et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer 42 (2006) 2205-2211
18. Abner A., Connolly J.L., Recht A., et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88 (2000) 1072-1077
19. Fisher E.R., Land S.R., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Twelve-year observations concerning lobular carcinoma in situ. Cancer 100 (2004) 238-244
20. Shoker B.S., and Sloane J.P. DCIS grading schemes and clinical implications. Histopathology 35 (1999) 393-400
21. Page D.L., Dupont W.D., Rogers L.W., et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 75 (1995) 1197-1200
22. Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275 (1996) 913-918
23. Lagios M.D., Westdahl P.R., Margolin F.R., et al. Duct carcinoma in situ: Relationship of extent of non-invasive disease to frequency of occult invasion, multicentricity, lymph node metastases and short term treatment failure. Cancer 50 (1982) 1309-1314
24. Boyages J., Delaney G., and Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 85 (1999) 616-628
25. Silverstein M.J., Barth A., Poller D.N., et al. Ten-years result comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31 (1995) 1425-1427
26. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 (1998) 441-452
27. Cuzick J. Treatment of DCIS-Results from clinical trials. Surg Oncol 12 (2003) 213-219
28. Recht A., and Houlihan M.J. Axillary lymph nodes and breast cancer. Cancer 76 (1995) 1491-1512
29. Degnim A.C., Griffith K.A., Sabel M.S., et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98 (2003) 2307-2315
30. Wilkie C., White L., Dupont E., et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190 (2005) 563-566
31. Cox C.E., Nguyen K., Gray R.J., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS?. Am Surg 67 (2001) 513-519
32. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
33. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
34. Giordano S.H., Cohen D.S., Buzdar A.U., et al. Breast carcinoma in men: A population-based study. Cancer 101 (2004) 51-57
35. Giordano S.H., Buzdar A.U., and Hortobagyi G.N. Breast cancer in men. Ann Intern Med 137 (2002) 678-687
36. Sasco A.J., Lowenfels A.B., and Pasker-de Jong P. Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53 (1993) 538-549
37. Easton D.F., Steele L., Fields P., et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61 (1997) 120-128
38. Kwiatkowska E., Teresiak M., Filas V., et al. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 9 (2003) 4452-4459
39. Ottini L., Masala G., D'Amico C., et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: A population-based study in Italy. Cancer Res 63 (2003) 342-347
40. Borgen P.L., Wong G.Y., Vlamis V., et al. Current management of male breast cancer. A review of 104 cases. Ann Surg 215 (1992) 451-457
41. Cutuli B., Lacroze M., Dilhuydy J.M., et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A (1995) 1960-1964
42. Yildirim E., and Bergeroglu U. Male breast cancer: A 22-year experience. Eur J Surg Oncol 24 (1998) 548-552
43. Giordano S.H. A review of the diagnosis and management of male breast cancer. Oncologist 24 (2005) 548-479
44. Stierer M., Rosen H., Weitensfelder W., et al. Male breast cancer: Austrian experience. World J Surg 19 (1995) 687-692
45. Woo J.C., Yu T., and Hurd T.C. Breast cancer in pregnancy: A literature review. Arch Surg 138 (2003) 91-98
46. Antonelli N.M., Dotters D.J., Katz V.L., et al. Cancer in pregnancy: A review of the literature. Part I. Obstet Gynecol Surv 51 (1996) 125-134
47. Anderson B.O., Petrek J.A., Byrd D.R., et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 3 (1996) 204-211
48. King R.M., Welch J.S., Martin J.K., et al. Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet 160 (1985) 228-232
49. Lethaby A.E., O'Neill M.A., Mason B.H., et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 67 (1996) 751-755
50. Nettleton J., Long J., Kuban D., et al. Breast cancer during pregnancy: Quantifying the risk of treatment delay. Obstet Gynecol 87 (1996) 414-418
51. Nugent P., and O'Connell T.X. Breast cancer and pregnancy. Arch Surg 120 (1985) 1221-1224
52. Mazze R.I., and Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: A registry study of 5405 cases. Am J Obstet Gynecol 161 (1989) 1178-1185
53. Berry D.L., Theriault R.L., Holmes F.A., et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17 (1999) 855-861
54. Kuerer H.M., Gwyn K., Ames F.C., et al. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131 (2002) 108-110
55. Kal H.B., and Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6 (2005) 328-333
56. Malone K.E., Daling J.R., Thompson J.D., et al. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years of first-degree family history. JAMA 279 (1998) 922-929
57. Couch F.J., DeShano M.L., Blackwood M.A., et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336 (1997) 1409-1415
58. Nelson H.D., Huffman L.H., Fu R., et al. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 143 (2005) 362-379
59. Abeliovich D., Kaduri L., Lerer I., et al. The founder mutations 185delAG and 538insC in BRCA1 and 6174delT in BRCA2 appear in 60 percent of ovarian cancer and 30 percent of early-onset breast cancer patients among Ashkenazi Jewish women. Am J Hum Genet 60 (1997) 505-514
60. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22 (2004) 1055-1062
61. Hartmann L.C., Seller T.A., Schaid D.J., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93 (2001) 1633-1637
62. Pennisi V.R., and Capozzi A. Subcutaneous mastectomy data: A final statistical analysis of 1500 patients. Aesthetic Plast Surg 13 (1989) 15-21
63. Eisen A., Lubinski J., Klijn J., et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: An international case-control study. J Clin Oncol 23 (2005) 7491-7496
64. Robson M., Svahn T., McCormick B., et al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series. Cancer 103 (2005) 44-51
65. Chabner E., Nixon A., Gelman R., et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 16 (1998) 2045-2051